The EBLICIMET brand, founded in 2010 (United States), from
496 sister brands
and 17479 competing brands.
EBLICIMET is a brand of BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York.
The sector of EBLICIMET is Drug Manufacturers.
EBLICIMET is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY)
